Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor

Although still commonly used in clinical practice to screen and diagnose prostate cancer, there are numerous weaknesses of prostate-specific antigen (PSA) testing, including lack of specificity and the inability to distinguish between aggressive and indolent cancers. A promising prostate cancer biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Po-Yuan, Cheng, Kai-Lun, McGuffin-Cawley, James D., Shieu, Fuh-Sheng, Samia, Anna C., Gupta, Sanjay, Cooney, Matthew, Thompson, Cheryl L., Liu, Chung Chiun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263563/
https://www.ncbi.nlm.nih.gov/pubmed/25586028
http://dx.doi.org/10.3390/bios2040377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263563/
https://www.ncbi.nlm.nih.gov/pubmed/25586028
http://dx.doi.org/10.3390/bios2040377

Ejemplares similares